Liu, Yu’e
Wang, Yanjin
Yang, Yanrong
Weng, Linjun
Wu, Qi http://orcid.org/0000-0001-6182-5274
Zhang, Jin
Zhao, Pengcheng
Fang, Lan
Shi, Yufeng http://orcid.org/0000-0003-3833-1035
Wang, Ping
Funding for this research was provided by:
National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (31830053, 82073274, 19QA1406700)
Article History
Received: 8 June 2022
Revised: 31 January 2023
Accepted: 14 February 2023
First Online: 7 March 2023
Competing interests
: Y.S. holds a share of Nanjing Shijiang Medicine Technology Co. LTD, which develops mitochondrial targeting reagents for human health. All the other authors declare no competing interests.